Table 1 The clinical characteristics of DLBCL patients
From: SIRT1 rs3758391 polymorphism and risk of diffuse large B cell lymphoma in a Chinese population
Characteristics | No. (n = 206) n (%) |
|---|---|
Gender | |
Male | 97 (47.09) |
Female | 109 (52.91) |
Age | |
≤ 60 | 145 (70.39) |
> 60 | 61 (29.61) |
B symptom | |
+ | 64 (31.07) |
− | 142 (68.93) |
Subtype | |
GCB | 63 (30.58) |
nGCB | 143 (69.42) |
Ann-arbor stage | |
I–II | 132 (64.08) |
III–IV | 74 (35.92) |
IPI score | |
0–1 | 106 (51.46) |
2–5 | 100 (48.54) |
ECOG | |
0–1 | 193 (93.69) |
2–5 | 13 (6.31) |
Extra nodal sites | |
+ | 126 (61.17) |
− | 80 (38.83) |
Bulky tumor (> 10 cm) | |
+ | 48 (23.30) |
− | 158 (76.70) |
Bone marrow involvement | |
+ | 11 (5.34) |
− | 195 (94.66) |
Elevated LDH | |
+ | 85 (41.26) |
− | 121 (58.73) |
Elevated β2-MG | |
+ | 61 (29.61) |
− | 145 (70.39) |
HBV infection | |
+ | 45 (21.84) |
− | 161 (78.16) |
KI-67 | |
≤ 75% | 96 (46.60) |
> 75% | 110 (53.40) |